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The Ames Seralyzer uses solid phase chemistry coupled with
reflectance spectroscopy to measure levels of serum alanine
aminotransferase (serum ALT). The study reported here was
carried out to evaluate the performance of the Seralyzer method
compared to conventional analyses carried out on a Coulter Dacos
discrete random access analyser using Boehringer (BCL) reagents
conforming to SCE specications at 37 C. Clinically acceptable
accuracy and precision were obtained. The effect of bilirubin and
haemoglobin on the test was investigated. Increased levels of
bilirubin in sera did not affect the estimation but the presence of
high haemoglobin levels produced significant interference. The
overall practicality of the Seralyzer was assessed and the method
wasfound to be particularly suitablefor the estimation ofurgent or
high risk samples in the laboratory orfor use by suitably trained
personnel in other clinical areas.
Introduction
Several discrete analysers have been designed for use in
the solid phase. Generally, the principle of operation
involves reacting an analyte with a dry chemical matrix
incorporating the reagents. This produces a change in the
visible or ultraviolet spectrum which is measured using
reflectance spectroscopy. The advantages of this kind of
technology are many: the single test reaction pads need
no preparation, have a long shelf life and the methods use
simple standard procedures.
The Seralyzer Blood Chemistry Analyser manufactured
by Ames Division (Miles Ltd) was specifically designed
to measure reflectance levels using dedicated test strips.
The theory and principles of operation of the analyser
have been fully described by Zipp and Hornby [1] and
Stevens and Newall [2]. The performance of several
analytical procedures have been reported, including
serum or plasma urea, glucose, urate [2], CK, LDH [3]
and AST [4].
This paper describes the evaluation of a new ALT
(alanine aminotransferase, European Enzyme No.
2.6.1.2) determination using the Seralyzer. The results
obtained are compared with analyses carried out on the
same day on a Coulter Dacos discrete random access
analyser using Boehringer (BCL) reagents conforming to
SCE specifications at 37 C. The effect of bilirubin and
haemoglobin on the test was investigated and the overall
practicality assessed.
Method
The ALT test strip contains a matrix which, in the
presence of ALT enzyme, produces a coloured dye
complex. The reaction sequence is as follows:
ALT
Alanine + 0-ketoglutarate----* pyruvate + glutamate
pyruvate oxidase, Mg2+
Pyruvate + phosphate + O2
thiaminepyrophosphate
acetylphosphate + CO2 + H202
H202 + 4-AAP + DCHBS
peroxidase
quinoneimine dye + H20
where 4-AAP 4-aminoantipyrine and DCHBS
3,4-dichloro-2-hydroxybenzenesulphonate.
The Seralyzer reflectometer system measures the col-
oured quinoneimine dye formed on the test strip by
monitoring the total change in reflectance at 530 nm at
37 C over a period of 4 min. The assay requires 30 tl of
serum diluted 3 in water which is pipetted on to the dry
reaction pad on the strip. The test strip is immediately
inserted into the reflectometer. If the concentration of
ALT is greater than 250 IU 1-1 an over-range code shows
on the display. In this event a further 9-fold dilution ofthe
serum is made and the sample is reanalysed.
Protocol
Each day, a two-point calibration was performed on the
Seralyzer using reconstituted lyophilised calibrator
serum. Duplicate analyses were carried out on three
control sera (Gilford Normal, Abnormal and Wellcome)
and up to 12 patient samples. Daily calibration was for
evaluation purposes only: in practice, the calibration is
stable and would not be required so frequently.
Samples from the controls and patients were analysed
singly on the Dacos analyser for ALT and for bilirubin. A
total of 115 clinical samples were analysed.
Results
Between-batch precision was analysed using the data
given by the daily control results. As the data in table
indicate, the Seralyzer gave higher mean readings for the
Gilford N (p <0"001) and lower for Gilford A (p 0"004)
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Table 1. Analytical precision of the Seralyzer and Dacos ALT methods using duplicate testing of control sera.
Seralyzer (n 15)
Replicate Replicate 2
Mean s.d. Mean s.d.
Dacos (n 15)
Replicate Replicate 2
Mean s.d. Mean s.d.
GilfordN 24"5 3"3 24-2 3"9 19"3 1.4 19-8 1-8
GilfordA 74"8 5" 76"4 5"2 77-7 2"8 78" 2"8




Figure 1. Comparison of serum ALT levels (IU 1-1) between
Seralyzer and Dacos analysers.
than the Dacos results, but the same for Wellcome serum
(p >0"2). The results for the Seralyzer were slightly less
consistent day to day than the Dacos, but were acceptable
for clinical purposes.
Analysis of duplicate Seralyzer results showed the 115
valid pairs of observations greater than 10 IU -t had a
mean difference of 1"03 and a standard deviation (SD) of
1"04, with a correlation coefficient of 0"99.
Comparisons of the Seralyzer and Dacos results are
shown in figure 1. Calculations using ALT results with
levels less than 250 IU 1-1 gave a very good correlation
coefficient of 0"99 (p <0"001) when comparing the
Seralyzer to the Dacos method.
The slope was 0.91 and the intercept 2"0. Serum with
levels ofALT greater than 250 IU 1-1, which had to be
reanalysed after further dilution, showed little change in
statistical characteristics up to a level of approx. 740
IU 1-1, the highest levels analysed.
Twenty samples with bilirubin concentrations greater
than 40 btmol 1-1 were available for analysis (max 230
btmol 1-1). The Seralyzer and Dacos results forALT were
very similar (p <0"001, r 0"99). As the Dacos method is
known not to be affected by high bilirubin levels, it can be
construed that bilirubin does not interfere with this












Figure 2. Comparison of Seralyzer and Dacos ALT results for
clinical samples with increased concentrations of bilirubin. (Log
ALT IU l- horizontal axis, log bilirubin #mol l- vertical
axis.)
the two methods on the x-axis and log bilirubin results on
they-axis. The logarithm ofthe results were used in figure
2 to give a clearer visual representation. The various
levels of bilirubin show little effect on the ALT compari-
sons. Further evidence was obtained by adding increas-
ing amounts of human bilirubin to serum: enzyme
estimations showed no significant effect by either method,
at bilirubin concentrations up to 120 bmol l-1.
The red pigment ofhaemoglobin can affect reflectometric
measurements. The presence of visual haemoglobin in
serum depresses the level of ALT as measured by the
Seralyzer. To investigate this, increasing amounts of
haemoglobin were added to serum. The ALT results
show a significant interference effect only when the
haemoglobin concentration is greater than about 100
mg d1-1 (figure 3). This is the approximate level at which
haemoglobin becomes visible.
Discussion
Serum ALT results showed a good correlation between
the Ames Seralyzer and the standard laboratory pro-
cedure. Satisfactory results were obtained for serum
samples tested with ALT levels from 10-800 IU 1-1.
Increased levels of bilirubin do not affect the test.
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Figure 3. Seralyzer ALT measurements on a clinical sample with
added amounts ofhaemoglobin.
Samples showing any visible haemolysis should not be
processed.
Day-to-day imprecision for the reflectometer is accept-
able for clinical purposes but was marginally greater than
that for the automated laboratory analyser. One cause of
imprecision may be due to small variations in the daily
two-point calibrations. However, in practice, calibration
would only be carried out once for each batch of strips.
The analyser flags when the calibration is not within
preset levels but to identify possible inaccuracies, controls
at high and low concentration can be processed after each
calibration, according to good laboratory practice.
Although the system is reliable and simple to use, some
expertise is required for the dilution of the serum and for
standardization of technique. Because of these aspects, it
would operate most effectively in the laboratory environ-
ment or by well trained appropriate personnel in other
clinical situations.
The Seralyzer method is particularly suited for process-
ing small batches of urgent analyses and for high risk
samples as the reaction strips are totally disposable and
the machine easily decontaminated.
In conclusion, this reflectometric method for ALT is
simple and convenient, and with care and suitable
samples, produces clinically useful results which compare
well with standard laboratory techniques.
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